The Global Medtech Industry: Rewiring Medtech in a Post-Pandemic World

AdvaMed, the Medtech Association, released the following statement thanking the FDA Center for Radiological Health (CDRH) for recently hosting an event in New Delhi to discuss regulatory policies and best practices for ensuring medical technology reaches patients. The event, called “Minds to Markets: Regulatory Considerations in Med-Tech,” advances US-India cooperation on medtech supply chain through greater regulatory alignment.

AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker regarding the conclusion of the World Trade Organization Ministerial conference in Abu Dhabi.

Scott Whitaker, President and CEO of AdvaMed, the Medtech Association, urged the White House to delay the sale and privatization of the Federal Helium Reserve until concerns about resulting supply chain disruptions are resolved.

AdvaMed President and CEO Scott Whitaker released the following statement regarding the 14th Ministerial-level Trade Policy Forum held in New Delhi, India:

The investments being made in our domestic semiconductor chip manufacturing base under the CHIPS and Science Act are critical for the medtech industry and the millions of patients who rely on the life-saving devices the medtech industry develops.

In times of crisis, the medtech industry stands as a pillar of strength, providing innovative solutions to address immediate needs and foster resilience. Discover a few NGOs that AdvaMed members can partner with to help make a positive impact around the world.

As the International Civil Aviation Organization (ICAO) Dangerous Goods Panel meets this week, AdvaMed, the Medtech Association, led a group of 24 global medtech organizations in expressing concerns about the panel’s proposed regulations on the transport of dangerous goods aboard aircraft.

The 17th edition of EY’s Pulse of the Industry report offers a chance to take stock of the US and European medtech industry’s performance in 2023.